How to choose a biologic agent considering comorbidities of bronchial asthma
{{output}}
Biologic therapies have revolutionized the treatment of severe asthma. However, the selection of the optimal biologic agent remains challenging because of the heterogeneity of disease phenotypes and frequent comorbidities. This mini-review explored the clinica... ...